营业利润 更改
Alaunos Therapeutics USD -1.01M 175K 2026-03
Amgen USD 4.61B 777M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Baxter International USD 276M 210M 2026-06
Biogen USD -243.8M 758.1M 2026-06
Bioline Rx USD -3M 382K 2026-03
Bristol-Myers Squibb USD 299M 3.07B 2026-06
Celltrion KRW 12.9B 822.77M 2026-03
Corcept Therapeutics USD 41.3M 90.9M 2026-06
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Curis USD -11.52M 3.64M 2026-03
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Divis Laboratories Ltd INR 11.29B 3.15B 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Incyte USD 700.4M 376.22M 2026-06
Intrexon USD -60.84M 26.62M 2024-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
J&J USD 7.48B 860M 2026-06
Kangmei Pharma CNY -10.94M 15.75M 2026-03
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Merck USD 840M 2.72B 2026-06
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Novartis USD 4.75B 515M 2026-06
Organigram Holdings CAD -9.79M 10.33M 2026-03
Ovoca Bio EUR -173K 990K 2025-12
Pfizer USD 667M 4.32B 2026-06
Pharma Mar EUR -1.4M 2.03M 2026-06
PTC Therapeutics USD 45.89M 127.51M 2026-03
Qiagen NV USD 116.63M 5.25M 2026-03
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sartorius EUR 164M 3.3M 2026-06
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
TG Therapeutics USD 21.67M 13.12M 2026-06
Tilray USD -20.01M 9.34M 2025-09
Verastem USD -44.9M 3.42M 2026-03
Zealand Pharma A/S -539M 168.05M 2026-03
Zz Pientze Pharmaceu CNY 837.81M 336.48M 2026-03